Sunstone Life Science Ventures’ is a European, early-stage investor based in Copenhagen. We invest in drug development opportunities across the European Life Science sector, and prefer to make our initial investment in companies raising Series A/B rounds based on solid in-vivo preclinical data and a well understood mechanism of action that fits well into the pathology. We seek opportunities which improve patient outcome and have the potential of offering solutions that are more efficient for the health care system. Our team brings together a diverse set of professional experience: from entrepreneurial ventures to corporate management and financial services. Our background allows us to support our portfolio companies on a breadth of issues, ranging from high strategic level to specific operational issues.